BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21403118)

  • 1. Myocardial infarction with intracardiac thrombosis as the presentation of acute promyelocytic leukemia: diagnosis and follow-up by cardiac magnetic resonance imaging.
    Cahill TJ; Chowdhury O; Myerson SG; Ormerod O; Herring N; Grimwade D; Littlewood T; Peniket A
    Circulation; 2011 Mar; 123(10):e370-2. PubMed ID: 21403118
    [No Abstract]   [Full Text] [Related]  

  • 2. Don't just stand there, do something: strategies for the prevention of early death in acute promyelocytic leukemia: a commentary.
    Tallman MS; Manji GA
    Blood Cells Mol Dis; 2011 Feb; 46(2):173-4. PubMed ID: 21227722
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute myocardial infarction as a finding of acute promyelocytic leukemia-related coagulation disorder.
    Özkurt ZN; Aypar E; Sarifakiogullari S; Taçoy G; Özdag M; Kahraman S; Çengel A
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):949-52. PubMed ID: 26523810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
    Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of retinoic acid sensitivity in relapsed acute promyelocytic leukemia with extramedullary involvement.
    Thomas X; Fiere D; Archimbaud E
    Leukemia; 1994 Mar; 8(3):520-1. PubMed ID: 8127158
    [No Abstract]   [Full Text] [Related]  

  • 6. Blue toes and a new pair of shoes--challenges in diagnosis and treatment of acute myelogenous leukemia.
    Mar N; Gorgan MA; Dailey ME; Vredenburgh JJ
    Am J Hematol; 2013 Dec; 88(12):1090-3. PubMed ID: 23918652
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy-free treatment of acute promyelocytic leukemia.
    Ravandi F
    Clin Adv Hematol Oncol; 2015 Aug; 13(8):498-500. PubMed ID: 26351810
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical observation of low dose of heparin to treat coagulation disorders of acute promyelocytic leukemia].
    Chen S; Chen S; Yu Y; Chen J; Guo Y; Xu L; Zhang K; Shen Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):459-60. PubMed ID: 24857222
    [No Abstract]   [Full Text] [Related]  

  • 10. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.
    Breccia M; Cimino G; Alimena G; De Carolis S; Lo Coco F; Mandelli F
    Haematologica; 2002 Feb; 87(2):ELT12. PubMed ID: 11836189
    [No Abstract]   [Full Text] [Related]  

  • 11. Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia.
    Gillis S; Dann EJ; Eldor A
    Eur J Haematol; 1995 Jan; 54(1):59-60. PubMed ID: 7859878
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment for acute promyelocytic leukemia].
    Fujita H
    Rinsho Ketsueki; 2014 Oct; 55(10):1817-26. PubMed ID: 25297745
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleeding and thrombosis in acute promyelocytic leukemia.
    Choudhry A; DeLoughery TG
    Am J Hematol; 2012 Jun; 87(6):596-603. PubMed ID: 22549696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation therapy for acute promyelocytic leukemia.
    Fenaux P; Degos L
    N Engl J Med; 1997 Oct; 337(15):1076-7. PubMed ID: 9321537
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute promyelocytic leukemia following ulcerative colitis].
    Suzuki Y; Nakase K; Nagaya S; Tamaki S; Tanigawa M; Ikeda T; Tsuji K; Miyanishi E
    Rinsho Ketsueki; 1995 Jul; 36(7):707-9. PubMed ID: 7563602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an Alert System on Quality Indicators in Patients With Acute Promyelocytic Leukemia.
    Blackburn LM; Bauchmire N; Bender S; Tomlinson-Pinkham K; Roberts S; Rosan S
    Clin J Oncol Nurs; 2016 Oct; 20(5):523-7. PubMed ID: 27668372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid response to induction in a case of acute promyelocytic leukemia with MYC amplification on double minutes at diagnosis.
    Zuberi L; Adeyinka A; Kuriakose P
    Cancer Genet Cytogenet; 2010 Apr; 198(2):170-2. PubMed ID: 20362234
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute promyelocytic leukemia: impact of hemorrhagic complications on response to induction chemotherapy and survival.
    Humphries JE; Hess CE; Stewart FM
    South Med J; 1990 Oct; 83(10):1157-61. PubMed ID: 2218655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible bone marrow necrosis after all-trans retinoic acid induction therapy for acute promyelocytic leukaemia.
    Lakhwani S; Raya JM; González-Brito G; Álvarez-Argüelles H; Brito ML; Hernández-Nieto L
    Pathology; 2011 Aug; 43(5):515-7. PubMed ID: 21753723
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia.
    Vitale C; Jabbour E; Lu X; Yabe M; Kanagal Shamanna R; Daver N; Pemmaraju N; Bueso-Ramos CE; Takahashi K
    Am J Hematol; 2016 Jun; 91(4):E274-6. PubMed ID: 26798971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.